Elevated Leukemia Incidence Is Found in World Trader Center (WTC) Rescue and Recovery Workers
Overall cancer incidence also elevated, particularly in thyroid and prostate cancers
Responders who worked at the World Trade Center site after the attacks on September 11, 2001, have an increased overall cancer incidence compared to the general population, particularly in thyroid cancer, prostate cancer, and, for the first time ever reported, leukemia, according to a Mount Sinai study published in JNCI Cancer Spectrum in January.
Following the attacks on the World Trade Center, 50,000 workers were involved in rescue and recovery, with many of them caught directly in the dust cloud from the collapsing towers. From then until cleanup of the site ended in June 2002, workers were potentially exposed to an array of toxins later shown to cause adverse health effects, including cancer.
This study examined cancer incidence in responders including law enforcement, construction, and telecommunications workers, and found an increased overall cancer incidence, with the greatest elevation in thyroid cancer. It is the first to show an increase in leukemia, which is known to occur after exposure to occupational carcinogens, including benzene fuel and other sources that existed at the World Trade Center site, in some cases at low levels of exposure and with a latency of several years from exposure.
Researchers also found that neither the length of time that first responders and recovery workers worked on the World Trade Center site, nor the intensity of their exposure, had any bearing on the development of the elevated cancers. However, some risk factors—such as responders’ age on September 11, their gender, and whether they were smokers at the time—were associated with increased cancer risk, underlining the need for continued surveillance of World Trade Center rescue and recovery workers.
“This study showed increased incidence of several cancer types compared to previously conducted studies with shorter follow-up periods,” said Susan Teitelbaum, PhD, Professor of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai and one of the lead authors. “Because of the long latency period of many types of cancer, it is possible that increased rates of other cancers, as well as World Trade Center exposure health issues, may emerge after longer periods of study.”
Researchers studied post-September 11 cancer incidence among 28,729 rescue and recovery workers via cancer registry data from New York, New Jersey, Connecticut, Pennsylvania, Florida, and North Carolina from 2002 through 2013. Although the incidence of certain cancers, such as lung, was not elevated in this study’s findings, researchers believe that may be due to the long time periods over which these cancers develop.
This work was supported by contract 200-2017-93325 from the Centers for Disease Control and Prevention / National Institute for Occupational Safety & Health.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.